Clinical Trials Browser

Unknown × OTHER_GOV × Recurrence × Clear all

NCT06088719 2023-10-18

Safety of Omitting Axillary Surgery in Breast Cancer Patients With Isolated Chest Wall Recurrence

Breast Neoplasms, Recurrence

NCT01675219 2023-04-13

Fluorescence Cystoscopy and Optimized MMC in Recurrent Bladder Cancer (FinnBladder 9)

Phase 3 Unknown

Urinary Bladder Neoplasms, Recurrence

NCT05704231 2023-01-30

The Effect of Telephone-Assisted Smoking Cessation Program in Patients Diagnosed With Non-Muscle Invasive Bladder Cancer

Phase NA Unknown

Non-Muscle Invasive Bladder Neoplasms, Recurrence, Smoking, Disease Progression

NCT04021212 2022-05-11

Pituitary Adenoma and Serum Lipid

Pituitary Diseases, Pituitary Neoplasms, Recurrence

NCT03789513 2022-02-16

AIMA-CC

Phase NA Unknown

Uterine Cervical Neoplasms, Recurrence, HIV Infections, Papillomavirus Infections

NCT05137860 2022-01-18

Efficacy of the Use of Bortezomib for the Treatment of Relapsed Leukemia or Positive MRD

Phase 4 Unknown

LymphoidOther hematologic neoplasm

Recurrence, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01611766 2021-06-10

Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)?

Phase 3 Unknown

Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

NCT03664869 2021-04-01

FB10

Phase 3 Unknown

Urinary Bladder Neoplasms, Recurrence

NCT02733380 2020-04-01

Chidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell Lymphoma

Phase 2 Unknown

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT02747732 2019-04-23

Study of Ibrutinib in Combination With Bendamustine and Rituximab for Patients With Relapsed/Refractory Aggressive BCL

Phase 2 Unknown

Neoplasms, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT03881761 2019-03-21

CD19/20 Bispecific Nanobody-derived CAR-T Cells in B Cell Lymphoma

Phase 1 Unknown

Recurrence, Lymphoma, B-Cell

NCT03881774 2019-03-21

Cord Blood Derived CAR-T Cells in Refractory/Relapsed B Cell Malignancies

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell

NCT03601624 2018-11-14

MM-POM-2018

Phase 2 Unknown

Multiple Myeloma, Recurrence, Disease Progression

NCT03666221 2018-09-11

Nimotuzumab for Recurrent Nasopharyngeal Carcinoma

Phase 2 Unknown

Nasopharyngeal Carcinoma, Recurrence

NCT03540303 2018-05-30

Cytoplasmic Activated PD-1 CAR T Cells in Refractory/Relapsed B Cell Lymphoma

Phase 1 Unknown

Lymphoma, Lymphoma, Non-Hodgkin, Recurrence

NCT02471547 2016-04-28

Intravesically Heated Thermo-chemotherapy With Mitomycin-C Prior to TURBT

Phase NA Unknown

Carcinoma, Transitional Cell, Recurrence

NCT01380275 2014-09-25

Trial of Docetaxel and Irinotecan (DI) for Recurrent or Refractory Bone and Soft Tissue Sarcomas.

Phase 2 Unknown

Recurrence, Sarcoma

NCT02004795 2013-12-09

BNCT and IG-IMRT for Recurrent Head and Neck Cancer

Phase 1/2 Unknown

Head and Neck Neoplasms, Recurrence

NCT01086488 2011-07-08

FOSCAN

Phase 2 Unknown

Nasopharyngeal Carcinoma, Recurrence

NCT01300156 2011-02-21

Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin (ESHAOx) for Refractory or Relapsed Hodgkin's Lymphoma (HL)

Phase 2 Unknown

Hodgkin Disease, Lymphoma, Recurrence

NCT00815555 2008-12-30

CYP2D6 Genotyping by AmpliChipTM CYP450 for Tamoxifen-Treated Breast Cancer Patients

Breast Neoplasms, Recurrence